Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
Condition(s) studied
Investigational drug(s) / intervention(s)
Theraband chest compression: Chest compression applicated via a Red Theraband over the upper or lower chest region
Study summary
The goal of this clinical trial is to investigate the effects of elastic chest compression on functional exercise capacity and respiratory performance of patients with COPD. The main questions it aims to answer are:
Is there difference in functional exercise capacity and respiratory performance without or with the use of elastic upper chest compression? Is there difference in functional exercise capacity and respiratory performance between the use of elastic upper chest compression and elastic lower chest compression?
Participants will:
Be evaluated under three conditions on three different days: without elastic compression, with upper chest compression, and with lower chest compression, with the order of compression application randomly assigned.
The functional capacity and respiratory muscle performance of all patients will be evaluated.
The days for evaluation will be at least three days apart from each other.
Eligibility
Primary outcome measure(s)
- Functional exercise capacity — up to 3 weeks
6 minute walk test measured in meters - Respiratory muscle performance — up to 3 weeks
Maximum inspiratory (MIP) and expiratory pressures (MEP) in mmH2O - Respiratory flow performance — up to 3 weeks
peak inspiratory (PIFR) and expiratory flows (PEFR) in liter per minute
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| National Taiwan University Hospital Hsinchu Branch | Hsinchu | Taiwan | Recruiting |
More National Taiwan University Hospital trials in Taiwan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06519474 on ClinicalTrials.gov ↗ ← All trials in Taiwan